000838511 001__ 838511
000838511 005__ 20231023125112.0
000838511 0247_ $$2Handle$$a2128/17599
000838511 037__ $$aFZJ-2017-07103
000838511 1001_ $$0P:(DE-Juel1)132024$$aStrodel, Birgit$$b0$$eCorresponding author
000838511 245__ $$aLearning from simulations
000838511 260__ $$c2017
000838511 3367_ $$2DataCite$$aText
000838511 3367_ $$0PUB:(DE-HGF)4$$2PUB:(DE-HGF)$$aCommunication$$bcomm$$mcomm$$s1520582817_31514
000838511 3367_ $$2BibTeX$$aMISC
000838511 3367_ $$2ORCID$$aOTHER
000838511 3367_ $$2DINI$$aOther
000838511 3367_ $$04$$2EndNote$$aPersonal Communication
000838511 500__ $$aPan European Networks: Health 02: 91-92
000838511 520__ $$aAlzheimer’s disease (AD) is the most common form ofdementia in the elderly. Currently, one in eight persons abovethe age of 65 is suffering from this disorder and it is expectedthat there will be 100 million persons affected by 2040. In AD, thesmall molecular weight amyloid-ß peptide (Aß) has been identifiedas a clinical hallmark in disease development and progression.
000838511 536__ $$0G:(DE-HGF)POF3-553$$a553 - Physical Basis of Diseases (POF3-553)$$cPOF3-553$$fPOF III$$x0
000838511 8564_ $$uhttp://edition.pagesuite-professional.co.uk/html5/reader/production/default.aspx?pubname=&edid=07dcafa0-b8b5-4a5d-b3d1-cbd8f366eeab
000838511 8564_ $$uhttps://juser.fz-juelich.de/record/838511/files/PEN.pdf$$yOpenAccess
000838511 8564_ $$uhttps://juser.fz-juelich.de/record/838511/files/PEN.gif?subformat=icon$$xicon$$yOpenAccess
000838511 8564_ $$uhttps://juser.fz-juelich.de/record/838511/files/PEN.jpg?subformat=icon-1440$$xicon-1440$$yOpenAccess
000838511 8564_ $$uhttps://juser.fz-juelich.de/record/838511/files/PEN.jpg?subformat=icon-180$$xicon-180$$yOpenAccess
000838511 8564_ $$uhttps://juser.fz-juelich.de/record/838511/files/PEN.jpg?subformat=icon-640$$xicon-640$$yOpenAccess
000838511 8564_ $$uhttps://juser.fz-juelich.de/record/838511/files/PEN.pdf?subformat=pdfa$$xpdfa$$yOpenAccess
000838511 8767_ $$86762$$92017-08-24$$d2017-10-06$$eAPC$$jZahlung erfolgt$$zGBP 2000,-
000838511 909CO $$ooai:juser.fz-juelich.de:838511$$popenCost$$pVDB$$pdriver$$pOpenAPC$$popen_access$$popenaire
000838511 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000838511 9141_ $$y2017
000838511 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)132024$$aForschungszentrum Jülich$$b0$$kFZJ
000838511 9131_ $$0G:(DE-HGF)POF3-553$$1G:(DE-HGF)POF3-550$$2G:(DE-HGF)POF3-500$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bKey Technologies$$lBioSoft – Fundamentals for future Technologies in the fields of Soft Matter and Life Sciences$$vPhysical Basis of Diseases$$x0
000838511 9201_ $$0I:(DE-Juel1)ICS-6-20110106$$kICS-6$$lStrukturbiochemie$$x0
000838511 9801_ $$aAPC
000838511 9801_ $$aFullTexts
000838511 980__ $$acomm
000838511 980__ $$aVDB
000838511 980__ $$aUNRESTRICTED
000838511 980__ $$aI:(DE-Juel1)ICS-6-20110106
000838511 980__ $$aAPC
000838511 981__ $$aI:(DE-Juel1)IBI-7-20200312